Ana Isabel Torres-Suárez (Ana-Isabel Torres-Suárez, Ana I Torres-Suárez, A I Torres-Suárez)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Pharmaceutics

Cancers

Drug delivery and translational research

Drugs

Universidad Complutense de Madrid

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Complutense de Madrid

Spain

Headmistress :: Institute of Industrial Pharmacy

Universidad Complutense de Madrid Facultad de Farmacia

Spain

Professor :: Pharmaceutical Technology

Publications

Laura Gómez-Lázaro, Cristina Martín-Sabroso, Juan Aparicio-Blanco, Ana Isabel Torres-Suárez
Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols. Pharmaceutics 16 (1) (2024)
Laura Gómez-Lázaro, Cristina Martín-Sabroso, Juan Aparicio-Blanco, Ana Isabel Torres-Suárez
Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols. Pharmaceutics 16 (1) (2024)
Teresa Areses-Huete, Damián Cordoba-Diaz, Ana Isabel Torres-Suárez, Manuel Córdoba
Development and Characterization of a Microemulsion Containing a Cannabidiol Oil and a Hydrophilic Extract from Sambucus ebulus for Topical Administration. Pharmaceutics 16 (6) (2024)
Teresa Areses-Huete, Damián Cordoba-Diaz, Ana Isabel Torres-Suárez, Manuel Córdoba
Development and Characterization of a Microemulsion Containing a Cannabidiol Oil and a Hydrophilic Extract from Sambucus ebulus for Topical Administration. Pharmaceutics 16 (6) (2024)
Laura Gómez-Lázaro, Cristina Martín-Sabroso, Juan Aparicio-Blanco, Ana Isabel Torres-Suárez
Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols. Pharmaceutics 16 (1) (2024)
Ana Isabel Fraguas-Sánchez, Dolores Hernán, Consuelo Montejo, Justin L Poklis, Aron H Lichtman, Ana Isabel Torres-Suárez
Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release. Drug delivery and translational research (2023)
Ana Isabel Fraguas-Sánchez, Dolores Hernán Pérez de la Ossa, Consuelo Montejo, Justin L Poklis, Aron H Lichtman, Ana Isabel Torres-Suárez
Correction to: Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release. Drug delivery and translational research (2023)
Ana-Isabel Fraguas-Sánchez, Irene Lozza, Ana Isabel Torres-Suárez
Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 14 (5) (2022)
Cristina Martín-Sabroso, Mario Alonso-González, Ana Fernández-Carballido, Juan Aparicio-Blanco, Damián Cordoba-Diaz, Federico Navarro-García, Manuel Córdoba, Ana Isabel Torres-Suárez
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Cristina Martín-Sabroso, Irene Lozza, Ana Isabel Torres-Suárez, Ana-Isabel Fraguas-Sánchez
Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics 13 (10) (2021)
Cristina Martín-Sabroso, Ana Isabel Torres-Suárez, Mario Alonso-González, Ana Fernández-Carballido, Ana-Isabel Fraguas-Sánchez
Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives. Pharmaceutics 14 (1) (2021)
Ana-Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez, Marie Cohen, Florence Delie, Daniel Bastida-Ruiz, Lucile Yart, Cristina Martín-Sabroso, Ana Fernández-Carballido
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment. Pharmaceutics 12 (5) (2020)
Rebeca Simancas-Herbada, Ana Fernández-Carballido, Juan Aparicio-Blanco, Karla Slowing, Jorge Rubio-Retama, Enrique López-Cabarcos, Ana Isabel Torres-Suárez
Controlled Release of Highly Hydrophilic Drugs from Novel Poly(Magnesium Acrylate) Matrix Tablets. Pharmaceutics 12 (2) (2020)
Alexandre Pérez-López, Cristina Martín-Sabroso, Ana Isabel Torres-Suárez, Juan Aparicio-Blanco
Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom. Pharmaceutics 12 (11) (2020)
Ana-Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez
Development of Innovative Formulations for Breast Cancer Chemotherapy. Cancers 12 (11) (2020)
A I Fraguas-Sánchez, C Martín-Sabroso, A Fernández-Carballido, Ana Isabel Torres-Suárez
Current status of nanomedicine in the chemotherapy of breast cancer. Cancer chemotherapy and pharmacology 84 (4) (2019)
Ana Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez
Medical Use of Cannabinoids. Drugs 78 (16) (2019)
Juan Aparicio-Blanco, Ignacio A Romero, David K Male, Karla Slowing, Luis García-García, Ana Isabel Torres-Suárez
Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood-Brain Barrier Both in Vitro and in Vivo. Molecular pharmaceutics 16 (5) (2019)
Ana-Isabel Fraguas-Sánchez, Cristina Martín-Sabroso, Ana Isabel Torres-Suárez
Insights into the effects of the endocannabinoid system in cancer: a review. British journal of pharmacology 175 (13) (2018)

Ana Isabel Torres-Suárez.css-eqlu8i{font-size:small;padding-left:4px;} (Ana-Isabel Torres-Suárez, Ana I Torres-Suárez, A I Torres-Suárez)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Isabel Torres-Suárez (Ana-Isabel Torres-Suárez, Ana I Torres-Suárez, A I Torres-Suárez)